ASML reported Q2 revenue of €9.3B and net income of €2.92B, beating expectations (€8.8B revenue, €2.62B net income), with revenue +21% YoY and net income nearly +28%. The company raised full-year guidance to €43B–€45B (midpoint ~+21% vs prior €34B–€39B) and lifted gross margin guidance by +300 bps to 55% at the midpoint. Management also expects advanced chipmaking equipment supply to increase by ~30% over the next three years and anticipates a 75% jump in memory-related revenue this year, supporting an analyst view of stronger earnings growth into 2028.
The market mechanism here is not just "AI spending is healthy"; it is that the bottleneck in leading-edge lithography and memory-capex recovery keeps pricing power concentrated in the one vendor that every serious node migration must pass through. That makes ASML less of a cyclical equipment name and more of a toll collector on the entire 2nm/HBM transition, which should support multiple expansion if order visibility holds through the next two quarters.
The more interesting second-order winner is the broader semi-capex complex: AMAT, LRCX, and KLAC should see follow-through if memory makers actually convert rhetoric into tool purchases, but they are more exposed to digestion risk and mix shifts than ASML. If memory pricing rolls over before capex ramps, those peers can underperform even if ASML stays resilient, because the market will question whether the equipment cycle is broadening or just concentrated in one or two customer build-outs.
Risk is mostly 1-3 month: the stock has already priced a lot of good news, so any flat bookings, export-control chatter, or commentary implying customer spending is back-half loaded could compress the multiple quickly. Over 6-18 months, the thesis only breaks if foundry/customer capex is delayed or if memory makers choose to preserve balance sheets rather than chase supply share; that would matter more than any one-quarter revenue beat.
Contrarian view: consensus may be overconfident that memory shortages automatically translate into durable capex. In semis, shortages often invite a surge of capacity spending that fixes pricing faster than suppliers expect, and once HBM/DRAM pricing normalizes, the urgency can fade. The stock is strongest if management can keep raising supply guidance without signaling a demand pull-forward; otherwise the current move looks like a quality-premium re-rating rather than a clean earnings inflection.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment